Inhibrx SG&A Expense (Quarterly) Analysis

Inhibrx Inc (INBX)

34.30 -0.16 (-0.46%) USD | NASDAQ | Apr 19, 15:02

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	7.832M
September 30, 2023	7.889M
June 30, 2023	7.263M
March 31, 2023	6.397M
December 31, 2022	5.323M
September 30, 2022	5.347M
June 30, 2022	5.402M
March 31, 2022	5.051M
December 31, 2021	3.645M
September 30, 2021	2.848M
June 30, 2021	2.853M

Date	Value
March 31, 2021	3.009M
December 31, 2020	2.215M
September 30, 2020	1.622M
June 30, 2020	1.532M
March 31, 2020	1.467M
December 31, 2019	4.434M
September 30, 2019	1.481M
June 30, 2019	1.636M
March 31, 2019	1.467M
June 30, 2018	0.989M
March 31, 2018	0.911M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.467M

Minimum

Mar 2020

7.889M

Maximum

Sep 2023

4.066M

Average

3.645M

Median

Dec 2021

SG&A Expense (Quarterly) Benchmarks